Metastatic Esophageal Squamous Cell Carcinoma

14 clinical trials · Condition

Record	Firm	Date
Real-world Experience of ICIs Plus Chemotherapy for Advanced ESCC. (NCT05142709)	Fudan University	2021-10-31
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014) (NCT04949256)	Merck Sharp & Dohme LLC	2021-07-28
Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers (NCT04460937)	National Cancer Institute (NCI)	2021-04-09
The Ave-CRT Study for Newly Diagnosed Metastatic Esophageal Squamous Cell Carcinoma (NCT03800953)	National Taiwan University Hospital	2019-03-20
Real-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC. (NCT06190652)	Tianjin Medical University Cancer Institute and Hospital	2018-10-13
Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell Carcinoma (NCT01472419)	Samsung Medical Center	2012-03-01
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer (NCT01142388)	National Cancer Institute (NCI)	2010-09-21

Every clearance here is in the API, with alerts when new ones post.